Lipoprotein disorders and cardiovascular risk

Area of Science:

• Lipid metabolism and cardiovascular genetics
• Human genetics and disease etiology
• Atherosclerosis and lipoprotein research

Background:

• Dyslipoproteinaemia, characterized by abnormal lipoprotein levels, is a major contributor to human diseases, primarily atherosclerotic vascular disease.
• Key risk factors include elevated low-density lipoprotein cholesterol (LDL-C), very low-density lipoproteins (VLDL), lipoprotein(a), and reduced high-density lipoproteins (HDL-C), alongside severe hypertriglyceridemia.
• Lifestyle and genetic factors interplay in the development of these disorders, which often remain asymptomatic until critical organ damage occurs.

Purpose of the Study:

• To review the significant role of genetic lipoprotein disorders in human disease.
• To focus on monogenic causes linked to coronary artery disease and new insights into high-density lipoprotein disorders.
• To discuss the implications for screening and treatment strategies, particularly for pediatric populations.

Main Methods:

• Literature review focusing on genetic aetiologies of dyslipoproteinaemia.
• Analysis of monogenic disorders associated with coronary artery disease.
• Examination of novel genetic causes for high-density lipoprotein disorders.

Main Results:

• Genetic factors are a primary driver for various dyslipoproteinaemias, impacting cardiovascular health.
• Monogenic disorders represent a significant cause of premature coronary artery disease.
• Emerging research identifies new genetic underpinnings for high-density lipoprotein abnormalities.

Conclusions:

• Genetic lipoprotein disorders are crucial in human pathology, necessitating a thorough understanding for effective management.
• Early identification and intervention, considering disease severity and long-term vascular risk, are vital, especially in children.
• Further research into genetic causes and therapeutic benefits is essential for improving patient outcomes.